Physician

Ramakrishna Thokala, MD

According to 2025 Medicare claims, Ramakrishna Thokala, MD (NPI: 1295969699) practices nephrology in the Midland, TX market, with the plurality of this provider's patient population coming from Midland, TX. This provider's primary affiliated billing organization is MIDLAND KIDNEY CARE PLLC (NPI: 1881067973; TIN: 475493793) and primary practice location at 79703-5118. Thokala is affiliated with the Texoma Clinical Partners ACO, LLC (ACO ID: A4585), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Thokala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 384 traditional Medicare patients, billed 1,699 HCPCS/CPT codes, and received $188,141 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,516 prescription claims across 290 beneficiaries totaling $563,029 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 174 claims. Open Payments data shows 7 records totaling $137. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $17,988 to $563,029. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,447 to $2,497.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	354	878	$74,667
2016	280	695	$51,370
2017	N/R	N/R	N/R
2018	355	1,045	$127,784
2019	449	2,362	$268,974
2020	418	2,313	$303,166
2021	411	2,055	$277,062
2022	395	1,589	$205,274
2023	410	1,533	$207,516
2024	384	1,699	$188,141

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	116	314	$17,988
2016	99	284	$12,553
2017	N/R	11	$431
2018	131	305	$67,022
2019	242	1,344	$420,566
2020	268	1,759	$749,316
2021	287	1,873	$866,073
2022	251	1,437	$681,639
2023	274	1,405	$506,766
2024	290	1,516	$563,029

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	30	$1,265
2016	N/R	57	$2,240
2017	N/R	22	$834
2018	N/R	N/R	N/R
2019	N/R	374	$22,969
2020	22	287	$14,834
2021	N/R	186	$5,681
2022	N/R	191	$7,111
2023	N/R	175	$5,363
2024	N/R	174	$2,902

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	108	288	$268
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	103	127	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	129	284	$83
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	116	369	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	121	198	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	104	4,080	$399,633
Auryxia	Ferric Citrate	17	1,110	$60,273
Veltassa	Patiromer Calcium Sorbitex	22	746	$16,803
Farxiga	Dapagliflozin Propanediol	11	750	$13,370
Sevelamer Carbonate	Sevelamer Carbonate	92	3,260	$10,937

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	44	$793
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	48	$665
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	36	$649
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	35	$574
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	11	$221

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$137	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ramakrishna Thokala, MD?

Tedicare shows public-source Medicare data for Ramakrishna Thokala, MD (NPI 1295969699), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramakrishna Thokala, MD have ACO affiliation data?

Ramakrishna Thokala, MD is shown with ACO affiliation data for Texoma Clinical Partners ACO, LLC (MSSP, ACO ID A4585), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ramakrishna Thokala, MD?

Ramakrishna Thokala, MD is linked to MIDLAND KIDNEY CARE PLLC (billing NPI 1881067973) in the available physician profile data.

Does Ramakrishna Thokala, MD have Open Payments data?

Ramakrishna Thokala, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.